-
The Role of MicroRNA in Hepatitis C Virus Replication
Xiao-Qiong Duan, Shi-Lin Li, Yu-Jia Li, Bing Liu, Pei-Bing Zeng, Chun-Hui Yang, Li-Min Chen
-
Hepatocellular Carcinoma in Non‐alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
György Baffy
-
Found in Translation
George Y. Wu
-
The Effect of Adrenal Replacement Therapy on Rates of Fungal Colonization and Mortality in Critically Ill Patients Awaiting Liver Transplantation
Stephanie G. Yi, Archana R. Sadhu, Stephen L. Jones, Krista Turner, Howard Monsour, Kevin Donahue, Xuefeng Xia, A. Osama Gaber, R. Mark Ghobrial, Sherilyn Gordon Burroughs
-
Update on the Development of Anti‐Viral Agents Against Hepatitis C
Kristin L. Macarthur, Robert Smolic, Martina V. Smolic, Catherine H. Wu, George Y. Wu
-
Development of Tivantinib as Treatment for Hepatocellular Carcinoma
Lillian Lou
-
Polymorphism Near the Interleukin‐28B Gene and Anti‐Hepatitis C Viral Response
Yasuhiro Asahina, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe
-
Genome‐Wide Association Study Reveals Host Genetic Factors for Liver Diseases
Nao Nishida, Katsushi Tokunaga, Masashi Mizokami
-
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B
Hong Tang, Jamie Griffin, Steven Innaimo, Lois Lehman-Mckeeman, Cyril Llamoso
-
Drug‐ and Herb‐Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
Rolf Teschke, Axel Eickhoff, Johannes Schulze
-
The Discovery and Development of Boceprevir: A Novel, First‐generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease
Anita Y. M. Howe, Srikanth Venkatraman